Rystiggo Interactions
There are 304 drugs known to interact with Rystiggo (rozanolixizumab), along with 1 disease interaction. Of the total drug interactions, 45 are major, 250 are moderate, and 9 are minor.
- View all 304 medications that may interact with Rystiggo
- View Rystiggo disease interactions (1)
Most frequently checked interactions
View interaction reports for Rystiggo (rozanolixizumab) and the medicines listed below.
- Actemra (tocilizumab)
- Actimmune (interferon gamma-1b)
- Adcetris (brentuximab)
- Adcirca (tadalafil)
- Addyi (flibanserin)
- Adzynma (apadamtase alfa, recombinant)
- Aimovig (erenumab)
- Ajovy (fremanezumab)
- albuterol
- albuterol / ipratropium
- Andembry (garadacimab)
- baclofen
- Eliquis (apixaban)
- Emgality (galcanezumab)
- Farxiga (dapagliflozin)
- Fasenra (benralizumab)
- levothyroxine
- lisinopril
- Mestinon (pyridostigmine)
- potassium chloride
- prednisone
- pyridostigmine
- Repatha (evolocumab)
- rosuvastatin
- spironolactone
- Tezspire (tezepelumab)
- Trelegy Ellipta (fluticasone / umeclidinium / vilanterol)
- Ubrelvy (ubrogepant)
- Vyvgart (efgartigimod alfa)
- Xolair (omalizumab)
Rystiggo disease interactions
There is 1 disease interaction with Rystiggo (rozanolixizumab) which include:
Report options
QR code containing a link to this page
More about Rystiggo (rozanolixizumab)
- Rystiggo consumer information
- Compare alternatives
- Pricing & coupons
- Reviews (3)
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: selective immunosuppressants
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.